Intensity-Modulated Radiotherapy Using Implanted Fiducial Markers With Daily Portal Imaging: Assessment of Prostate Organ Motion

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 912-919

  Chen, Jergin ^a   Lee, R Jeffrey ^a   Handrahan, Diana ^b   Sause, William T ^a  

^a LDS HOSPITAL   (United States)

^b Statistical Data Center   (United States)

Author keywords

Daily localization; Intensity modulated radiotherapy; Portal imaging; Prostate cancer

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; MEDICAL IMAGING; TUMORS;

DAILY LOCALIZATION; INTENSITY-MODULATED RADIOTHERAPY; INTERFRACTION; PORTAL IMAGING; PROSTATE CANCER;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IMPLANTATION; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; ARTIFACTS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; MOVEMENT; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249650238     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.024     Document Type: Article

References (30)

1. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson Phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. J Am Med Assoc 294 (2005) 1233-1239
3. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
4. Valicenti R., Lu J., Pilepich M., et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated in the Radiation Therapy Oncology Group trials. J Clin Oncol 18 (2000) 2740-2746
5. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
6. Lee C.M., Lee R.J., Handrahan D.L., et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: Analysis of clinical and dosimetric factors. Urology 65 (2005) 114-119
7. Peeters S.T., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
8. Pinkawa M., Fischedick K., Asadpour B., et al. Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume. Int J Radiat Oncol Biol Phys 64 (2006) 835-841
9. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 62 (2005) 406-417
10. Wong J.R., Grimm L., Uematsu M., et al. Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: Prostate movements and dosimetric considerations. Int J Radiat Oncol Biol Phys 61 (2005) 561-569
11. Fung A.Y., Enke C.A., Ayyangar K.M., et al. Prostate motion and isocenter adjustment from ultrasound-based localization during delivery of radiation therapy. Int J Radiat Oncol Biol Phys 61 (2005) 984-992
12. Nederveen A.J., Dehnad H., van der Heide U.A., et al. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 68 (2003) 81-88
13. Stryker J.A., Shafer J., and Beatty R.E. Assessment of accuracy of daily set-ups in prostate radiotherapy using electronic imaging. Br J Radiol 72 (1999) 579-583
14. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 61 (2001) 127-133
15. Britton K.R., Takai Y., Mitsuya M., et al. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med 23 (2005) 14-24
16. Chandra A., Dong L., Huang E., et al. Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys 56 (2003) 436-447
17. Serago C.F., Chungbin S.J., Buskirk S.J., et al. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 1130-1138
18. Trichter F., and Ennis R.D. Prostate localization using transabdominal ultrasound imaging. Int J Radiat Oncol Biol Phys 56 (2003) 1225-1233
19. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42 (1998) 661-672
20. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50 (1999) 225-234
21. Little D.J., Dong L., Levy L.B., et al. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: Implications for treatment margins. Int J Radiat Oncol Biol Phys 56 (2003) 1218-1224
22. Scarbrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 378-387
23. Serago C.F., Buskirk S.J., Igel T.C., et al. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1585-1592
24. Crook J.M., Raymond Y., Salhani D., et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37 (1995) 35-42
25. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion: Implications for treatment planning. Int J Radiat Oncol Biol Phys 34 (1996) 451-458
26. Poggi M.M., Gant D.A., Sewchand W., et al. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 56 (2003) 1248-1251
27. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 63 (2005) 800-811
28. Schaly B., Bauman G.S., Song W., et al. Dosimetric impact of image-guided 3D conformal radiation therapy of prostate cancer. Phys Med Biol 50 (2005) 3083-3101
29. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 38 (1997) 73-81
30. Aubry J.F., Beaulieu L., Girouard L.M., et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 60 (2004) 30-39